Key result
RVOT pacing linked to ~81% fewer fixed myocardial perfusion defects versus RVA pacing.
Why the study?
Does right ventricular outflow tract (RVOT) pacing reduce myocardial perfusion defects compared to right ventricular apex (RVA) pacing in patients with permanent pacemakers?
Observational (n=31)
Does right ventricular outflow tract (RVOT) pacing reduce myocardial perfusion defects compared to right ventricular apex (RVA) pacing in patients with permanent pacemakers?
Absolute Event Rate: 13% vs 69%
p-value: p=0.003
RVOT pacing is associated with a significantly lower incidence of fixed myocardial perfusion defects on SPECT imaging compared to RVA pacing.
RVOT pacing should not yet change site selection; hypothesis-generating for perfusion benefits and requires prospective RCTs.
OBJECTIVE: The aim of the study was to compare the myocardial perfusion defects in patients with right ventricular outflow tract (RVOT) and right ventricular apex (RVA) pacing on stress-rest Tc-tetrofosmin myocardial perfusion single-photon emission computed tomography. PATIENTS AND METHODS: A total of 31 patients with permanent pacemakers (RVOT: 16 and RVA: 15) underwent stress-rest Tc-tetrofosmin involving a 1-day protocol. All patients underwent 1-day low-dose stress-gated and high-dose rest-gated Tc-tetrofosmin myocardial perfusion single-photon emission computed tomography imaging. RESULTS: Fixed perfusion defects were noted in 13 (42%) of 31 patients. Two (13%) patients of the RVOT group and 11 (69%) patients of the RVA group showed fixed perfusion defects (P=0.003). The fixed perfusion defects were located in the anteroapical, anteroseptal, and apical in the RVOT pacing group and in the apical, distal anteroseptal, inferoapical, distal anterior, and distal inferoseptal in the RVA pacing group. On univariate analysis, the incidence of perfusion defects was significantly associated with apical pacing, longer pQRS duration, and higher percentage of ventricular pacing. On multivariate analysis, the site of pacemaker insertion was found to be the most important pacemaker parameter determining the incidence of perfusion defects. Importantly, the duration of postpacemaker implantation did not show any significant relation to the incidence of perfusion defects. CONCLUSION: Fixed perfusion abnormalities are observed in patients with pacemakers and are independent of duration of time since implantation. RVOT pacing is associated with fewer incidences of myocardial perfusion abnormalities compared with RVA pacing.
No takes yet. Share an insight, caveat, or question.
Das et al. (2016) conducted an observational in Permanent pacemakers (n=31). Right ventricular outflow tract (RVOT) pacing vs. Right ventricular apex (RVA) pacing was evaluated on Fixed perfusion defects (p=0.003). Right ventricular outflow tract pacing was associated with a significantly lower incidence of fixed myocardial perfusion defects compared to right ventricular apex pacing (13% vs 69%; P=0.003).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: